FABBRI, Margherita
 Distribuzione geografica
Continente #
NA - Nord America 650
EU - Europa 400
AS - Asia 143
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Totale 1.201
Nazione #
US - Stati Uniti d'America 642
SE - Svezia 121
IT - Italia 100
CN - Cina 73
IE - Irlanda 65
FR - Francia 26
SG - Singapore 23
GB - Regno Unito 21
BE - Belgio 17
KR - Corea 12
UA - Ucraina 12
DE - Germania 11
FI - Finlandia 8
IN - India 8
VN - Vietnam 7
TW - Taiwan 6
IR - Iran 5
CA - Canada 4
JP - Giappone 4
NL - Olanda 4
AT - Austria 3
AU - Australia 3
HK - Hong Kong 3
MX - Messico 3
BR - Brasile 2
DK - Danimarca 2
ES - Italia 2
NG - Nigeria 2
PL - Polonia 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
HN - Honduras 1
LU - Lussemburgo 1
RO - Romania 1
TR - Turchia 1
Totale 1.201
Città #
Chandler 190
Dublin 64
Ashburn 61
Nyköping 30
Ann Arbor 27
Beijing 19
Medford 19
Fairfield 18
Princeton 18
Brussels 16
Singapore 16
Hangzhou 14
Torino 14
Turin 14
Wilmington 11
Seoul 10
Boston 8
Houston 8
Seattle 8
Helsinki 7
Cambridge 6
Hebei 6
Falls Church 5
London 5
Chengdu 4
Milan 4
Nanjing 4
Redmond 4
Rome 4
Taipei 4
Boardman 3
Cagliari 3
Corvallis 3
Dearborn 3
Jacksonville 3
Norwalk 3
Paris 3
Querétaro City 3
Riverton 3
Vienna 3
Abbiategrasso 2
Abuja 2
Amadora 2
Amsterdam 2
Bengaluru 2
Casoria 2
Changsha 2
Curitiba 2
Debica 2
Dong Ket 2
Florence 2
Kochi 2
Locate di Triulzi 2
Los Angeles 2
Malmo 2
Manchester 2
New York 2
Ottawa 2
Palo Alto 2
Redwood City 2
Saint Albans 2
San Francisco 2
San Giovanni in Persiceto 2
Southend 2
Suwon 2
Tianjin 2
Toronto 2
Tottenham 2
Valdagno 2
Washington 2
Woodbridge 2
Wuxi 2
Aarhus 1
Anguillara 1
Aprilia 1
Badlapur 1
Belfast 1
Birmingham 1
Bologna 1
Buffalo 1
Central 1
Charlotte 1
Clearwater 1
Cologne 1
Columbus 1
Crema 1
Cumberland 1
Dallas 1
Fremont 1
Guiyang 1
Gurgaon 1
Görwihl 1
Hefei 1
Hummelstown 1
Jinhua 1
Kashan 1
Kleinbettingen 1
Kontich 1
Kunming 1
Lamezia Terme 1
Totale 740
Nome #
Gut microbiota and metabolome distinctive features in parkinson disease: Focus on levodopa and levodopa carbidopa intrajejunal gel 161
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 96
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 92
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age 81
Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial 80
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications 73
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 63
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease 62
Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria? 60
Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson’s Disease? 59
Dysphagia predicts poor outcome in late-stage Parkinson's disease 55
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease 54
Levodopa/Carbidopa Intestinal Gel Long-Term Outcome in Parkinson's Disease: Focus on Dyskinesia 51
A new index to assess turning quality and postural stability in patients with Parkinson's disease 50
Home monitoring of motor fluctuations in Parkinson’s disease patients 48
Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease 45
Video analysis of long-term effects of levodopa-carbidopa intestinal gel on gait and posture in advanced Parkinson’s disease 42
Validation of the Italian version of the PSP Quality of Life questionnaire 42
Gait and axial postural abnormalities correlations in Parkinson's disease: A multicenter quantitative study 16
Postural abnormalities in Asian and Caucasian Parkinson's disease patients: A multicenter study 15
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 3
Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations 2
Self-Care Practices as a Mediator between Workaholism and Sleep–Wake Problems during COVID-19 2
Incidence and predictors of postural abnormalities in Parkinson's disease: a PPMI cohort study 1
Totale 1.253
Categoria #
all - tutte 5.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 2 2 3 6 8 6 8 0 2 5 9 12
2020/2021143 4 3 10 5 5 17 7 7 12 26 20 27
2021/2022361 10 7 11 25 36 10 23 27 7 50 89 66
2022/2023447 56 66 15 56 38 109 24 13 40 15 12 3
2023/2024230 24 40 12 10 24 18 6 43 2 11 11 29
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 1.253